GILEAD SCIENCES DENMARK ApS: Financial statements 2025
CVR: 30899032
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
GILEAD SCIENCES DENMARK ApS (CVR 30899032) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 186,763,801 and a net result of DKK 5,145,834 compared with DKK 5,860,294 the year before. That is an increase of 7.2% compared with the year before. The profit margin was 2.8%. Equity in the 2025 report amounted to DKK 65,134,048. The solvency ratio was 63%. The company had 10 employees in the financial year.
- Revenue
- DKK 186,763,801
- Gross Profit
- DKK 22,518,426
- Profit/Loss
- DKK 5,145,834
- Equity
- DKK 65,134,048
- Total Assets
- DKK 103,367,247
- Employees
- 10
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 186.8 mio. | 22.5 mio. | 5.1 mio. | 65.1 mio. | 10 |
| 2024 | 174.3 mio. | 21.8 mio. | 5.9 mio. | 60 mio. | 10 |
| 2023 | 109.9 mio. | 22.7 mio. | 3.2 mio. | 54.1 mio. | 13 |
| 2022 | 228.4 mio. | 27.5 mio. | 5.3 mio. | 50.9 mio. | 12 |
| 2021 | 174.8 mio. | 28 mio. | 3.9 mio. | 45.6 mio. | 13 |
Official annual report
How creditworthy is GILEAD SCIENCES DENMARK ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
GILEAD SCIENCES DENMARK ApS has won the tender "Amgros 2026 1.1061.a" issued by Amgros I/S worth 14,500,000 DKK.
GILEAD SCIENCES DENMARK ApS has won the tender "Amgros 2026 1.468.a" issued by Amgros I/S worth 1,890,000 DKK.
GILEAD SCIENCES DENMARK ApS has won the tender "Amgros 2026 1.865.a" issued by Amgros I/S worth 1,570,800,000 DKK.
GILEAD SCIENCES DENMARK ApS has won the tender "Amgros 2026 1.866.a" issued by Amgros I/S worth 55,650,000 DKK.
GILEAD SCIENCES DENMARK ApS has won the tender "Amgros 2026 1.810.a" issued by Amgros I/S worth 137,104,621 DKK.
GILEAD SCIENCES DENMARK ApS has published its annual report for 2024. Revenue came to DKK 174,279,220, and the net result was DKK 5,860,294.
GILEAD SCIENCES DENMARK ApS has won the tender "Amgros 2025 1.872.a" issued by Amgros I/S worth 998,250,000 DKK.
GILEAD SCIENCES DENMARK ApS has won the tender "Amgros 2025 1.870.a" issued by Amgros I/S worth 828,000,000 DKK.
GILEAD SCIENCES DENMARK ApS has won the tender "Amgros 2025 1.873.a" issued by Amgros I/S worth 244,500,000 DKK.
As of April 1, 2025, Josephine Yang Comiskey has joined the board of directors of GILEAD SCIENCES DENMARK ApS.
About GILEAD SCIENCES DENMARK ApS
GILEAD SCIENCES DENMARK ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 2007. The company is registered under the industry Agenturhandel med specialiseret varesortiment, bortset fra køretøjer. The management consists of Pau Arbos Vila, Anna Sophia Melén and Helene Annika Oscarsson. The board consists of Hans York-Julian Stücker (chair), Josephine Yang Comiskey and Juan Peche Marín-Lázaro. The company is owned by Gilead Sciences Ireland UC. The company has 11 employees (2018). In 2025, the company reported revenue of DKK 186,763,801 and a net result of DKK 5,145,834 compared with DKK 5,860,294 the year before. Equity in the 2025 report amounted to DKK 65,134,048.